Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo in high-risk MEC patients
NCT04817189Phase 4Completed
- Sponsor
- Helsinn
- Start
- Feb 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Started Feb 2021; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04817189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817189.